←
OncLive.com121,173 posts
OncLive.com avatar

OncLive.com

@OncLive

Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.

◷ Joined May 2009▧ 24,625 Photos and videos
OncLive.com avatar
OncLive.com@OncLive·12h

The CHMP of the EMA has issued a positive opinion recommending the marketing authorization of sintilimab plus pemetrexed and platinum-based chemotherapy for the first-line treatment of adult patients with nonsquamous NSCLC. #lcsm #oncology onclive.com/view/sintilimab-…

OncLive.com avatar
OncLive.com@OncLive·19h

Responses to investigational rinatabart sesutecan (Rina-S) in platinum-resistant ovarian cancer were seen across all FRα expression levels, including undetectable. Elizabeth K. Lee, MD, reviews the phase 2 RAINFOL-01 data. Watch the OncLive® Rapid Readout: hubs.li/Q04Dm7q00 @EKLee_MD @DanaFarber #ovca #gyncsm #IGCS2026

0:24
OncLive.com avatar
OncLive.com@OncLive·21h

Ryan J. Sullivan, MD, of @harvardmed and @MassGeneralNews, discusses HLA testing, liver-directed therapy, and emerging targeted and T-cell–based therapies for metastatic uveal melanoma. #melsm #oncology onclive.com/view/tcr-based-s…

OncLive.com avatar
OncLive.com@OncLive·Nov 17

⚛️ Primary results from the phase 3 ARTEMIS-011 trial evaluating Ris-Rez in R/R osteosarcoma showed improvements in efficacy compared with gemcitabine plus docetaxel, representing a promising new treatment option for patients Read more here 📰: onclive.com/view/ris-rez-imp… #oncology #scmsm

OncLive.com avatar
OncLive.com@OncLive·Nov 17

PFS improvements 📈 were shown for trastuzumab pamirtecan vs chemotherapy in HR+, HER2-low metastatic breast cancer, meeting the primary end point of the randomized, open-label phase 3 DYNASTY-Breast02 trial Read more here ➡️: onclive.com/view/trastuzumab… #oncology #bcsm

OncLive.com avatar
OncLive.com@OncLive·Nov 16

Adjuvant intravesical cretostimogene grenadenorepvec improved RFS vs surveillance in intermediate-risk non–NMIBC and high-grade Ta tumors, meeting the primary end point of the phase 3 PIVOT-006 trial #blcsm #oncology Read more: onclive.com/view/cretostimog…

OncLive.com avatar
OncLive.com@OncLive·Nov 16

Just in 👀: The European Commission has approved daraxonrasib for adult patients with metastatic pancreatic adenocarcinoma previously treated with at least 1 systemic therapy, regardless of whether a RAS mutation has been detected #pancsm #oncology Read more: onclive.com/view/daraxonrasi…

OncLive.com avatar
OncLive.com@OncLive·Nov 16

WATCH 👀: @jorgecortesmd of @ONealCancerUAB explains how lowering the ponatinib dose after response reduced arterial occlusive risk in resistant CML Full video ➡️: onclive.com/view/dr-cortes-o… #oncology #leusm

OncLive.com avatar
OncLive.com@OncLive·Nov 16

🚨BREAKING @FDA News🚨 The FDA has approved giredestrant plus everolimus for the treatment of adult patients with ER–positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer that has recurred during or after endocrine-based adjuvant therapy, or has progressed on 1 or more endocrine-based regimens in the metastatic setting Full details ➡️: onclive.com/view/fda-approve… #bcsm #oncology

Post attachment